paperId
stringlengths
13
45
doi
stringlengths
13
45
title
stringlengths
1
377
publicationYear
int64
1.85k
2.03k
publicationDate
stringlengths
4
10
type
stringclasses
18 values
publisher
stringclasses
232 values
containerTitle
stringlengths
3
149
volume
stringclasses
308 values
issue
stringclasses
204 values
page
stringlengths
1
13
issn
stringlengths
9
20
isbn
stringclasses
204 values
authors
stringlengths
2
37.4k
authorCount
int64
0
2.93k
firstAuthorAffiliation
stringlengths
5
506
isReferencedByCount
int64
0
67.6k
referenceCount
int64
0
1.6k
isOpenAccess
bool
2 classes
licenseUrl
stringclasses
67 values
funderNames
stringclasses
364 values
funderIds
stringclasses
303 values
url
stringlengths
29
61
pdfUrl
stringlengths
37
152
abstract
stringlengths
0
4.36k
subject
null
language
stringclasses
5 values
_run_id
stringclasses
50 values
_dataset_id
stringclasses
50 values
10.33140/atcp.04.01.15
10.33140/atcp.04.01.15
Thermal Simulation Analysis of a Lithium-Ion Battery
2,021
2021-03-21
journal-article
Opast Group LLC
Advances in Theoretical & Computational Physics
4
1
null
2639-0108
null
null
0
null
0
0
false
null
null
null
https://doi.org/10.33140/atcp.04.01.15
null
null
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.3724/sp.j.1105.2008.00915
10.3724/sp.j.1105.2008.00915
Sn/C COMPOSITES AS ANODE MATERIAL FOR LITHIUM ION BATTERY
2,009
2009-01-20
journal-article
China Science Publishing & Media Ltd.
Acta Polymerica Sinica
008
9
915-919
1000-3304
null
Linjian NING
1
null
0
15
true
null
null
null
https://doi.org/10.3724/sp.j.1105.2008.00915
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.64336/001c.83933
10.64336/001c.83933
Evaluating the potential of the lithium-carbon dioxide battery to replace the lithium-ion battery
2,023
2023-07-07
journal-article
Journal of High School Science
Journal of High School Science
7
3
null
2575-6206
null
Raghav Rajan
1
Saratoga High School, 20300 Herriman Ave, Saratoga, CA 95070, USA
0
0
true
https://creativecommons.org/licenses/by-nc-sa/4.0
null
null
https://doi.org/10.64336/001c.83933
https://jhss.scholasticahq.com/article/83933-evaluating-the-potential-of-the-lithium-carbon-dioxide-battery-to-replace-the-lithium-ion-battery.pdf
A recent advance in battery research has yielded the discovery of a lithium carbon-dioxide battery (Li-CO2). These batteries capture CO2 from the atmosphere to store and discharge energy. Li-CO2 batteries are an attempt at providing a large-scale battery solution for energy storage. They have a greater energy density (...
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1002/gch2.201870020
10.1002/gch2.201870020
Lithium‐Ion Batteries: New Insights into the Application of Lithium‐Ion Battery Materials: Selective Extraction of Lithium from Brines via a Rocking‐Chair Lithium‐Ion Battery System (Global Challenges 2/2018)
2,018
2018-02
journal-article
Wiley
Global Challenges
2
2
null
2056-6646, 2056-6646
null
Lihua He, Wenhua Xu, Yunfeng Song, Yunze Luo, Xuheng Liu, Zhongwei Zhao
6
School of Metallurgy and Environment Central South University Changsha Hunan 410083 P. R. China
5
0
true
http://creativecommons.org/licenses/by-nc/4.0/
null
null
https://doi.org/10.1002/gch2.201870020
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fgch2.201870020
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.54097/hset.v32i.4953
10.54097/hset.v32i.4953
Feasibility analysis of replacing lithium-ion battery with aqueous zinc-ion battery
2,023
2023-02-12
journal-article
Darcy & Roy Press Co. Ltd.
Highlights in Science, Engineering and Technology
32
null
108-114
2791-0210
null
Yi Tong
1
null
2
15
true
https://creativecommons.org/licenses/by-nc/4.0
null
null
https://doi.org/10.54097/hset.v32i.4953
https://drpress.org/ojs/index.php/HSET/article/download/4953/4800
lithium-ion battery is a battery with intercalated lithium compound as negative electrode material and non-aqueous solution as electrolyte. It is often used as energy supply system for mobile phones, electric vehicles and other equipment. However, due to the instability of lithium and the flammable organic electrolyte,...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.47390/ts-v4i3y2026n13
10.47390/ts-v4i3y2026n13
EXPERIMENTAL INVESTIGATION ON LITHIUM-ION BATTERY AGING UNDER UZBEKISTAN’S CLIMATE
2,026
2026-03-25
journal-article
LLC Scienceproblems Team
Techscience uz - Topical Issues of Technical Sciences
4
3
101-114
3030-3702
null
Tojiboy Almataev, Azizbek Zokirjonov
2
null
0
0
true
null
null
null
https://doi.org/10.47390/ts-v4i3y2026n13
https://techscience.uz/index.php/jurnal/article/download/299/206
Lithium-ion batteries constitute the primary energy source in modern electric vehicles however their long-term degradation represents a fundamental challenge in electrochemical energy-storage research. Temperature extremes such as intense summer heat or severe winter cold can intensify electrochemical degradation, hast...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1149/ma2007-02/10/663
10.1149/ma2007-02/10/663
From Lithium to Lithium Ion, a 40 Year Battery Generation (Battery Technology Award Address)
2,007
2007-09-28
journal-article
The Electrochemical Society
ECS Meeting Abstracts
MA2007-02
10
663-663
2151-2043
null
Michel Broussely
1
null
1
0
true
https://iopscience.iop.org/page/copyright
null
null
https://doi.org/10.1149/ma2007-02/10/663
https://iopscience.iop.org/article/10.1149/MA2007-02/10/663/pdf
Abstract not Available.
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1149/ma2015-03/2/560
10.1149/ma2015-03/2/560
Aqueous Sodium-Ion Battery As Post Lithium-Ion Battery
2,015
2015-07-15
journal-article
The Electrochemical Society
ECS Meeting Abstracts
MA2015-03
2
560-560
2151-2043
null
Shigeto Okada, Yusuke Kano, Kosuke Nakamoto
3
null
0
0
true
https://iopscience.iop.org/page/copyright
null
null
https://doi.org/10.1149/ma2015-03/2/560
https://iopscience.iop.org/article/10.1149/MA2015-03/2/560/pdf
Three kinds of secondary batteries, nickel metal hydride, Li-ion and Na/S battery were commercialized in Japan for the first time. Among them, Li-ion battery became the most popular power sources for PDA, because of the highest energy density. However, Li-ion battery is difficult to use for large-scale batteries, becau...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1016/j.focat.2019.02.052
10.1016/j.focat.2019.02.052
Lithium-ion battery anode including preloaded lithium
2,019
2019-03
journal-article
Elsevier BV
Focus on Catalysts
2019
3
7
1351-4180
null
null
0
null
0
0
true
https://www.elsevier.com/tdm/userlicense/1.0/
null
null
https://doi.org/10.1016/j.focat.2019.02.052
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.21275/sr221228121715
10.21275/sr221228121715
Battery Management Systems for Electric Vehicles using Lithium-Ion Batteries
2,022
2022-12-05
journal-article
International Journal of Science and Research
International Journal of Science and Research (IJSR)
11
12
1255-1261
2319-7064
null
Samudrala Hitesh Chandra, Jn Chandra Sekhar
2
null
1
0
false
null
null
null
https://doi.org/10.21275/sr221228121715
null
null
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.54254/2977-3903/11/2024102
10.54254/2977-3903/11/2024102
Quantum battery VS Lithium-ion battery
2,024
2024-09-04
journal-article
EWA Publishing
Advances in Engineering Innovation
11
1
49-59
2977-3903, 2977-3911
null
Yuhan Liu
1
Dulwich International High School Suzhou
3
0
false
null
null
null
https://doi.org/10.54254/2977-3903/11/2024102
null
This dissertation aims to research how quantum battery work and the comparisons between quantum battery and lithium-ion battery. Lithium-ion batteries are rechargeable energy storage devices that have become widely used in various applications, ranging from portable electronics to electric vehicles. They are known for ...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1595/205651314x685824
10.1595/205651314x685824
Secondary Lithium-Ion Battery Anodes: From First Commercial Batteries to Recent Research Activities
2,015
2015-01-01
journal-article
Johnson Matthey Plc
Johnson Matthey Technology Review
59
1
34-44
2056-5135
null
By Nicholas Loeffler, Dominic Bresser, Stefano Passerini, Mark Copley
4
Helmholtz Institute Ulm (HIU)Electrochemistry 1, Helmholtzstraße 11, 89081 UlmGermany
69
0
true
null
null
null
https://doi.org/10.1595/205651314x685824
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.7763/jocet.2016.v4.285
10.7763/jocet.2016.v4.285
Beneficial Effects of Active Charge Balancing in Lithium-Ion Battery Systems
2,015
2015
journal-article
EJournal Publishing
Journal of Clean Energy Technologies
4
3
225-228
1793-821X
null
M. Raeber, A. Heinzelmann, A. Taeschler
3
null
3
13
false
null
null
null
https://doi.org/10.7763/jocet.2016.v4.285
null
null
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1097/01.bmsas.0000452534.82188.7e
10.1097/01.bmsas.0000452534.82188.7e
Philips Lithium Ion Battery
2,014
2014-08-15
journal-article
Ovid Technologies (Wolters Kluwer Health)
Biomedical Safety & Standards
44
14
110
1080-9775
null
null
0
null
0
0
true
null
null
null
https://doi.org/10.1097/01.bmsas.0000452534.82188.7e
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.54097/x8wyc672
10.54097/x8wyc672
Feasibility analysis of replacing lithium-ion battery with sodium ion battery
2,024
2024-04-08
journal-article
Darcy & Roy Press Co. Ltd.
Highlights in Science, Engineering and Technology
90
null
81-86
2791-0210
null
Fang Hu, Hanjie Lin, Runliang Pan
3
null
2
0
true
https://creativecommons.org/licenses/by-nc/4.0
null
null
https://doi.org/10.54097/x8wyc672
https://drpress.org/ojs/index.php/HSET/article/download/19763/19350
Since the beginning of the 21st century, the global energy crisis has become a pressing issue, prompting researchers to explore more efficient ways of utilizing energy production and storage technologies in our daily lives. In recent years, there have been major improvements in lithium-ion batteries (LIBs) technology, ...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.7324/rjc.2017.1031767
10.7324/rjc.2017.1031767
LITHIUM RECOVERY OF SPENT LITHIUM-ION BATTERY USING BIOLEACHING FROM LOCAL SOURCES MICROORGANISM
2,017
2017
journal-article
Rasayan Journal of Chemistry
Rasayan Journal of Chemistry
null
null
null
0974-1496, 0976-0083
null
null
0
null
11
0
true
null
null
null
https://doi.org/10.7324/rjc.2017.1031767
http://rasayanjournal.co.in/admin/php/upload/227_pdf.pdf
null
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.21275/sr21902110259
10.21275/sr21902110259
Applications of Rechargeable Lithium - Ion Battery in Electric Vehicles: A Review
2,021
2021-09-27
journal-article
International Journal of Science and Research
International Journal of Science and Research (IJSR)
10
9
782-790
2319-7064
null
Zachary Bosire Omariba, Stephen Mageto Gichana
2
null
0
0
false
null
null
null
https://doi.org/10.21275/sr21902110259
null
null
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1007/s42823-020-00210-5
10.1007/s42823-020-00210-5
A criterion combined of bulk and surface lithium storage to predict the capacity of porous carbon lithium-ion battery anodes: lithium-ion battery anode capacity prediction
2,021
2021-10
journal-article
Springer Science and Business Media LLC
Carbon Letters
31
5
985-990
1976-4251, 2233-4998
null
Majid Shaker, Ali Asghar Sadeghi Ghazvini, Faisal Raza Qureshi, Reza Riahifar
4
null
36
23
true
https://www.springer.com/tdm
null
null
https://doi.org/10.1007/s42823-020-00210-5
https://link.springer.com/content/pdf/10.1007/s42823-020-00210-5.pdf
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1097/01.bmsas.0000413686.49660.f2
10.1097/01.bmsas.0000413686.49660.f2
Lithium Ion Battery, Charger
2,012
2012-04-15
journal-article
Ovid Technologies (Wolters Kluwer Health)
Biomedical Safety & Standards
42
7
52-53
1080-9775
null
null
0
null
0
0
true
null
null
null
https://doi.org/10.1097/01.bmsas.0000413686.49660.f2
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1103/physics.17.70
10.1103/physics.17.70
Lithium-Ion “Traffic Jam” Behind Reduced Battery Performance
2,024
2024-04-23
journal-article
American Physical Society (APS)
Physics
17
null
null
1943-2879
null
Rachel Berkowitz
1
null
0
1
true
https://link.aps.org/licenses/aps-default-license
null
null
https://doi.org/10.1103/physics.17.70
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1149/ma2010-02/11/1068
10.1149/ma2010-02/11/1068
Sulphur Lithium-Ion Power: A Novel, High Performance Polymer Tin/Sulphur Lithium-Ion Battery
2,010
2010-07-08
journal-article
The Electrochemical Society
ECS Meeting Abstracts
MA2010-02
11
1068-1068
2151-2043
null
Jusef Hassoun, Bruno Scrosati
2
null
0
0
true
https://iopscience.iop.org/page/copyright
null
null
https://doi.org/10.1149/ma2010-02/11/1068
https://iopscience.iop.org/article/10.1149/MA2010-02/11/1068/pdf
Abstract not Available.
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.33140/abbsr.05.01.06
10.33140/abbsr.05.01.06
New Rechargeable Lithium-ion AA Battery: More Economic and Eco-friendlier for Home Sleep Apnea Test
2,022
2022-01-10
journal-article
Opast Group LLC
Advances in Bioengineering and Biomedical Science Research
5
1
null
2640-4133
null
null
0
null
0
0
false
null
null
null
https://doi.org/10.33140/abbsr.05.01.06
null
Background: Sleep Apnea is a common sleep disorder and Home Sleep Apnea Test (HSAT) is one of the relatively safe and convenient diagnostic screening tools of Sleep Apnea. Nowadays popular devices for HSAT suggesting to use AA batteries for power supply and disposable alkaline battery is recommended in the guideline of...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1149/ma2010-03/1/834
10.1149/ma2010-03/1/834
Sulphur Lithium Ion Power: A Novel, High Performance Polymer Tin/Sulphur Lithium-Ion Battery
2,010
2010-05-27
journal-article
The Electrochemical Society
ECS Meeting Abstracts
MA2010-03
1
834-834
2151-2043
null
Jusef Hassoun, Bruno Scrosati
2
null
0
0
true
https://iopscience.iop.org/page/copyright
null
null
https://doi.org/10.1149/ma2010-03/1/834
https://iopscience.iop.org/article/10.1149/MA2010-03/1/834/pdf
Abstract not Available.
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.21275/sr21102173054
10.21275/sr21102173054
An Investigation into Sodium-Metal Battery as an Alternative to Lithium-Ion Batteries
2,021
2021-01-27
journal-article
International Journal of Science and Research
International Journal of Science and Research (IJSR)
10
1
110-115
2319-7064
null
M M Nishtha Singh
1
null
0
0
false
null
null
null
https://doi.org/10.21275/sr21102173054
null
null
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1097/01.bmsas.0000553626.05873.e0
10.1097/01.bmsas.0000553626.05873.e0
HeartStart MRx Lithium Ion Battery
2,019
2019-03-01
journal-article
Ovid Technologies (Wolters Kluwer Health)
Biomedical Safety & Standards
49
4
27-27
1080-9775
null
null
0
null
0
0
true
null
null
null
https://doi.org/10.1097/01.bmsas.0000553626.05873.e0
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1063/10.0001312
10.1063/10.0001312
Surface-modified silicon improves lithium-ion battery performance
2,020
2020-05-15
journal-article
AIP Publishing
Scilight
2020
20
null
2572-7907
null
Raima Larter
1
null
0
0
true
null
null
null
https://doi.org/10.1063/10.0001312
https://pubs.aip.org/aip/sci/article-pdf/doi/10.1063/10.0001312/11946667/201106_1_online.pdf
Investigators show that performance problems with silicon powders in lithium-ion batteries can be partially mitigated using surface modification techniques.
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1063/pt.5.7288
10.1063/pt.5.7288
A path to better lithium-ion battery performance
2,016
2016-07-28
journal-article
AIP Publishing
Physics Today
2016
07
null
1945-0699
null
null
0
null
0
0
false
null
null
null
https://doi.org/10.1063/pt.5.7288
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.4071/001c.129759
10.4071/001c.129759
Applying Machine Learning to the Smart Welding of Cylindrical Lithium-ion Battery Cells within Battery Modules
2,025
2025-02-13
journal-article
IMAPS - International Microelectronics Assembly and Packaging Society
IMAPSource Proceedings
2024
Symposium
null
2380-4505
null
Mike McKeown
1
Hesse Mechatronics, Inc.
0
0
true
null
null
null
https://doi.org/10.4071/001c.129759
https://imapsource.org/article/129759-applying-machine-learning-to-the-smart-welding-of-cylindrical-lithium-ion-battery-cells-within-battery-modules.pdf
Battery packs are used in transportation and energy storage applications to provide sufficient power for machine operation. There are various types of battery cell structures as well as numerous methods of interconnecting the battery cells. This paper will focus on cylindrical battery cells, the 21700 type, and Smart W...
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1063/10.0032402
10.1063/10.0032402
Building a better lithium-ion battery management system
2,024
2024-10-04
journal-article
AIP Publishing
Scilight
2024
40
null
2572-7907
null
Ben Ikenson
1
null
0
0
true
null
null
null
https://doi.org/10.1063/10.0032402
https://pubs.aip.org/aip/sci/article-pdf/doi/10.1063/10.0032402/20191549/401105_1_10.0032402.pdf
Combining machine learning with traditional method enhances predictive accuracy
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1063/pt.5.028617
10.1063/pt.5.028617
Longer-lasting lithium-ion battery for cell phones
2,015
2015-02-05
journal-article
AIP Publishing
Physics Today
2015
02
null
1945-0699
null
null
0
null
0
0
false
null
null
null
https://doi.org/10.1063/pt.5.028617
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1002/cssc.202400449
10.1002/cssc.202400449
All‐in‐All: Dead Lithium‐Ion Battery to Active Lithium‐Ion Capacitor
2,025
2025-01-02
journal-article
Wiley
ChemSusChem
18
1
null
1864-5631, 1864-564X
null
Akshay Manohar, Aranganathan Viswanathan, Yun‐Sung Lee, Vanchiappan Aravindan
4
Department of Chemistry Indian Institute of Science Education and Research (IISER) Tirupati 517619 India
10
35
true
http://onlinelibrary.wiley.com/termsAndConditions#vor
null
null
https://doi.org/10.1002/cssc.202400449
null
AbstractHere, we have developed lithium‐ion capacitors (LICs) with all the components, except the electrolyte solution, effectively recycled from the spent Lithium‐ion batteries (LIBs). Hybrid capacitors, such as LICs, are potential breakthroughs in electrochemical energy storage devices, where most research is focused...
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.23940/ijpe.18.12.p28.31843194
10.23940/ijpe.18.12.p28.31843194
Lithium-Ion Battery Management System for Electric Vehicles
2,018
2018
journal-article
Totem Publisher, Inc.
International Journal of Performability Engineering
null
null
null
null
null
Linjie Li
1
null
11
0
false
null
null
null
https://doi.org/10.23940/ijpe.18.12.p28.31843194
null
null
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.3390/batteries9100502
10.3390/batteries9100502
Stress Distribution Inside a Lithium-Ion Battery Cell during Fast Charging and Its Effect on Degradation of Separator
2,023
2023-10-02
journal-article
MDPI AG
Batteries
9
10
502
2313-0105
null
Mustapha Makki, Cheol W. Lee, Georges Ayoub
3
Department of Industrial and Manufacturing Systems Engineering, University of Michigan-Dearborn, Dearborn, MI 48128, USA
11
38
true
https://creativecommons.org/licenses/by/4.0/
Ford Motor Company (Ford-UM Alliance: Development of a Lithium Ion Battery Separator Aging Model)
null
https://doi.org/10.3390/batteries9100502
null
The automotive industry is rapidly transitioning to electric vehicles (EVs) in response to the global efforts to reduce greenhouse gas emissions. Lithium-ion battery (LIB) has emerged as the main tool for energy storage in electric vehicles. A widespread adoption of EVs, however, requires a fast-charging technology tha...
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1149/ma2016-01/2/268
10.1149/ma2016-01/2/268
Electrochemical Behaviors of All-Phosphate Lithium-Ion Battery and All-Phosphate Solid-State Lithium-Ion Battery
2,016
2016-04-01
journal-article
The Electrochemical Society
ECS Meeting Abstracts
MA2016-01
2
268-268
2151-2043
null
Shicheng Yu, Hermann Tempel, Roland Schierholz, Özgür Aslanbas, Josef Mertens, L.G.J. de Haart, Hans Kungl, Rüdiger-Albrecht Eichel
8
null
0
0
true
https://iopscience.iop.org/page/copyright
null
null
https://doi.org/10.1149/ma2016-01/2/268
https://iopscience.iop.org/article/10.1149/MA2016-01/2/268/pdf
Lithium-ion batteries are in focus of research around the world, due to their high volumetric and gravimetric energy density. For inorganic all-solid-state batteries since many years considerable effort has been devoted to the development of thin film batteries for their application in microelectronics [1, 2]. Recent r...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1016/j.resconrec.2022.106733
10.1016/j.resconrec.2022.106733
Is it worthwhile to recover lithium-ion battery electrolyte during lithium-ion battery recycling?
2,023
2023-02
journal-article
Elsevier BV
Resources, Conservation and Recycling
189
null
106733
0921-3449
null
Stephen Vanderburgt, Rafael M. Santos, Yi Wai Chiang
3
null
14
5
true
https://www.elsevier.com/tdm/userlicense/1.0/
Natural Sciences and Engineering Research Council of Canada
10.13039/501100000038
https://doi.org/10.1016/j.resconrec.2022.106733
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.54227/elab.20240015
10.54227/elab.20240015
Strategies of binder design for lithium-ion battery cathodes
2,024
2024
journal-article
Lab Academic Press
Energy Lab
2
null
null
2653-7702
null
Xianluo Hu
1
null
1
0
false
null
null
null
https://doi.org/10.54227/elab.20240015
null
Lithium-ion batteries (LIBs) are crucial for advancing green energy transformation and boosting industrial competitiveness, due to their high energy density, long cycle life, and environmental friendliness. Among the key components of LIBs, cathode materials play a pivotal role in determining overall battery performanc...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1149/ma2020-022278mtgabs
10.1149/ma2020-022278mtgabs
Synchronized Lithium and Lithium-Ion Battery Enabled to in-Situ Replenishment for Enhancing Battery Life
2,020
2020-11-23
journal-article
The Electrochemical Society
ECS Meeting Abstracts
MA2020-02
2
278-278
2151-2043
null
Manikandan Palanisamy, Mihit H. Parekh, Vilas G. Pol
3
null
0
0
true
https://iopscience.iop.org/page/copyright
null
null
https://doi.org/10.1149/ma2020-022278mtgabs
https://iopscience.iop.org/article/10.1149/MA2020-022278mtgabs/pdf
In-situ replenishment of formation cycle lithium-ion loss is considered for the development of longer-lasting rechargeable batteries that uses lithium-electrode, which acts as a reservoir and booster-electrode to mitigate the formation cycle capacity loss in mesocarbon microbeads (MCMB) anode vs LiFePO4 cathode and C-S...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1595/205651315x685445
10.1595/205651315x685445
Automotive Lithium-Ion Batteries
2,015
2015-01-01
journal-article
Johnson Matthey Plc
Johnson Matthey Technology Review
59
1
4-13
2056-5135
null
By Peter Miller
1
Johnson Matthey Battery SystemsOrchard Road, Royston, Hertfordshire, SG8 5HEUK
56
0
true
null
null
null
https://doi.org/10.1595/205651315x685445
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1093/ijlct/ctaf130
10.1093/ijlct/ctaf130
Lithium-ion battery equalization control strategy for photovoltaic-battery energy storage systems
2,025
2025-01-24
journal-article
Oxford University Press (OUP)
International Journal of Low-Carbon Technologies
20
null
1960-1965
1748-1325
null
Xia Zhao
1
College of intelligent manufacturing, ZhengZhou Technical College , No. 081, Zhengshang Road, Zhengzhou, Henan 450121 ,
1
18
true
https://creativecommons.org/licenses/by-nc/4.0/
null
null
https://doi.org/10.1093/ijlct/ctaf130
https://academic.oup.com/ijlct/article-pdf/doi/10.1093/ijlct/ctaf130/65360189/ctaf130.pdf
Abstract In this paper, the battery equalization technology of LiFePO4 battery energy storage system applied in photovoltaic is studied, using passive equalization circuit instead of active equalization circuit because passive equalization circuit is more suitable, and the shortcomings of the standard equalization cont...
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.55248/gengpi.07.0626.17b16
10.55248/gengpi.07.0626.17b16
Hybrid Quantum-Classical Optimization for Lithium-Ion Battery Systems and Resilient Supply Chains under Disruption
2,026
2026-06
journal-article
Genesis Global Publication
International Journal of Research Publication and Reviews
7
6
6102-6107
2582-7421
null
Padmaja Padmaja
1
null
0
0
false
null
null
null
https://doi.org/10.55248/gengpi.07.0626.17b16
null
The Laplace–Weierstrass (LW) transform combines the Laplace transform with Weierstrass Gaussian smoothing to deliver built-in regularization for dynamic systems characterized by noise and incomplete observations. This paper presents significant extensions including a rigorously justified existence theorem, explicit inv...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1002/er.3282
10.1002/er.3282
Correlating uncertainties of a lithium-ion battery - A Monte Carlo simulation
2,015
2015-05
journal-article
Hindawi Limited
International Journal of Energy Research
39
6
778-788
0363-907X
null
Wei Tong, Wei Qiang Koh, Erik Birgersson, Arun S. Mujumdar, Christopher Yap
5
Department of Mechanical Engineering; National University of Singapore; Singapore 117576
26
31
true
http://doi.wiley.com/10.1002/tdm_license_1.1
null
null
https://doi.org/10.1002/er.3282
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1149/ma2013-02/14/1092
10.1149/ma2013-02/14/1092
Fast Lithium Ion Conducting Ceramics for All-Solid-State Lithium-Ion Battery
2,013
2013-10-27
journal-article
The Electrochemical Society
ECS Meeting Abstracts
MA2013-02
14
1092-1092
2151-2043
null
Koichi Hamamoto, Toshiaki Yamaguchi, Hirofumi Sumi, Toshio Suzuki, Yoshinobu Fujishiro
5
null
0
0
true
https://iopscience.iop.org/page/copyright
null
null
https://doi.org/10.1149/ma2013-02/14/1092
https://iopscience.iop.org/article/10.1149/MA2013-02/14/1092/pdf
Abstract not Available.
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.24012/dumf.1528158
10.24012/dumf.1528158
Temperature Prediction of Lithium-ion Battery by CPSO-UKF
2,024
2024-09-30
journal-article
Dicle Universitesi Muhendislik Fakultesi Muhendislik Dergisi
DÜMF Mühendislik Dergisi
null
null
null
1309-8640
null
Göksu Taş
1
MANISA CELAL BAYAR UNIVERSITY
1
0
false
null
null
null
https://doi.org/10.24012/dumf.1528158
null
In this study, the temperature estimation of lithium-ion batteries is proposed by Chaos Particle Swarm Algorithm-Unscented Kalman Filter (UKF). 18650-type lithium-ion batteries are widely used in electric vehicles due to their compact design and long life. The accurate estimation of the temperature parameter of these b...
null
tr
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1016/s1350-4789(17)30204-0
10.1016/s1350-4789(17)30204-0
Secondary seal for lithium-ion battery cell
2,017
2017-06
journal-article
Auricle Global Society of Education and Research
Sealing Technology
2017
6
15
1350-4789
null
null
0
null
0
0
true
https://www.elsevier.com/tdm/userlicense/1.0/
null
null
https://doi.org/10.1016/s1350-4789(17)30204-0
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1016/s1350-4789(14)70313-7
10.1016/s1350-4789(14)70313-7
Improved seal for bipolar lithium-ion battery
2,014
2014-08
journal-article
Auricle Global Society of Education and Research
Sealing Technology
2014
8
14
1350-4789
null
null
0
null
1
0
true
https://www.elsevier.com/tdm/userlicense/1.0/
null
null
https://doi.org/10.1016/s1350-4789(14)70313-7
null
null
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.17303/jmsa.2023.7.103
10.17303/jmsa.2023.7.103
Nonstoichiometric Lithium Iron Phosphate for Lithium-Ion Battery Prepared by Supercritical Hydrothermal Synthesis
2,023
2023-12-15
journal-article
Jscholar Publishers
JMSA
7
1
null
null
null
Kyoo-Seung Han
1
null
1
0
false
null
null
null
https://doi.org/10.17303/jmsa.2023.7.103
null
null
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1149/ma2019-02/5/303
10.1149/ma2019-02/5/303
Prototype Aqueous Lithium-Ion Battery with a Lithium-Ion Conductive Solid Electrolyte Separator
2,019
2019-09-01
journal-article
The Electrochemical Society
ECS Meeting Abstracts
MA2019-02
5
303-303
2151-2043
null
Hayato Seki, Kazuomi Yoshima, Yasunobu Yamashita, Shinsuke Matsuno, Norio Takami
5
null
0
0
true
https://iopscience.iop.org/page/copyright
null
null
https://doi.org/10.1149/ma2019-02/5/303
https://iopscience.iop.org/article/10.1149/MA2019-02/5/303/pdf
Lithium-ion batteries (LIBs) with a non-aqueous electrolyte are capable of high energy density, high power output, and long cycle performance. These batteries are regarded as the most promising sources of power for electric vehicles (EVs), hybrid electric vehicles (HEVs), and grid storage. However, current LIBs pose a ...
null
null
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.3390/batteries10010038
10.3390/batteries10010038
A Review of Lithium-Ion Battery Recycling: Technologies, Sustainability, and Open Issues
2,024
2024-01-22
journal-article
MDPI AG
Batteries
10
1
38
2313-0105
null
Alessandra Zanoletti, Eleonora Carena, Chiara Ferrara, Elza Bontempi
4
INSTM and Chemistry for Technologies Laboratory, University of Brescia, Via Branze 38, 25123 Brescia, Italy
229
173
true
https://creativecommons.org/licenses/by/4.0/
Fondazione Cariplo through the grant “Tech4Lib–Spent Lithium ion battery recovery”, Fondazione Cariplo through the grant “Tech4Lib–Spent Lithium ion battery recovery”, Fondazione Cariplo through the grant “Tech4Lib–Spent Lithium ion battery recovery”, Fondazione Cariplo through the grant “Tech4Lib–Spent Lithium ion bat...
null
https://doi.org/10.3390/batteries10010038
null
Lithium-ion batteries (LIBs) are a widely used energy storage technology as they possess high energy density and are characterized by the reversible intercalation/deintercalation of Li ions between electrodes. The rapid development of LIBs has led to increased production efficiency and lower costs for manufacturers, re...
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1002/est2.208
10.1002/est2.208
Modeling of analog battery management system for single cell lithium ion battery
2,021
2021-08
journal-article
Wiley
Energy Storage
3
4
null
2578-4862, 2578-4862
null
Hemavathi S
1
CSIR‐Central Electrochemical Research Institute (CECRI) CSIR‐Madras Complex Chennai India
5
19
true
http://onlinelibrary.wiley.com/termsAndConditions#vor
null
null
https://doi.org/10.1002/est2.208
https://onlinelibrary.wiley.com/doi/pdf/10.1002/est2.208
AbstractThe Li‐ion battery is an energy storage system in consumer and industrial applications. Because of their cell and pack level protection, Li‐ion battery requires a battery management system (BMS). The important function of the BMS is to monitor and protect the Li‐ion battery cells and packs from fault conditions...
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.1063/5.0139773
10.1063/5.0139773
An insight into lithium-ion transport in germanium-doped lithium titanate anode through NMR spectroscopy and post-carbonization for anode applications in lithium-ion battery
2,023
2023-03-06
journal-article
AIP Publishing
Applied Physics Letters
122
10
null
0003-6951, 1077-3118
null
Sreejith O. V., Arunkumar Dorai, Junichi Kawamura, Murugan Ramaswamy
4
High Energy Density Batteries Research Laboratory, Department of Physics, Pondicherry University 1 , Puducherry 605 014, India
5
51
true
null
null
null
https://doi.org/10.1063/5.0139773
https://pubs.aip.org/aip/apl/article-pdf/doi/10.1063/5.0139773/16774496/103904_1_online.pdf
Adapting toward lithium titanate as a negative electrode for lithium-ion batteries led to the safest and long-lasting battery technology, especially for electric vehicle applications. However, the poor conductivity and lithium-ion diffusion of lithium titanate have to be addressed for widespread usage in next-generatio...
null
en
7TKe76uJOAyGT3oW8
A2XRduwfPh8b5vnpX
10.62830/mmj1-2-16b
10.62830/mmj1-2-16b
CAR-T Cell Therapy in Rheumatic Diseases
2,024
2024-06-15
journal-article
Max Healthcare Institute Limited
CAR-T Cell Therapy in Rheumatic Diseases
II
1
null
null
null
Hiren Kalyani, P.D Rath, Shwetal Chouhan, Mayank Goyal, Tejaswee Banavathu
5
null
0
0
false
null
null
null
https://doi.org/10.62830/mmj1-2-16b
null
CAR-T cell (Chimeric Antigen Receptor-T cell) therapy has revolutionized the treatment of various hematologic malignances. CD19 targeted CAR-T cell therapy is coming in a big way in rheumatic diseases. Recent case reports and case series have shown encouraging results in diseases like systemic lupus erythematosus (SLE)...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1093/med/9780190097653.003.0029
10.1093/med/9780190097653.003.0029
Hematopoietic Dyscrasias and Stem Cell Transplantation/CAR-T Cell Therapy
2,021
2021-02
book-chapter
Oxford University Press
Psycho-Oncology
null
null
203-214
null
9780190097653, 9780190097684
Jesse R. Fann, Nicole Bates
2
null
0
0
false
null
null
null
https://doi.org/10.1093/med/9780190097653.003.0029
null
This chapter describes the epidemiology, clinical presentation, assessment, and management of the many psychosocial issues and neuropsychiatric syndromes that may arise in patients with hematopoietic dyscrasias, including those undergoing hematopoietic stem cell transplantation (HSCT) and chimeric antigen receptor T (C...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.4018/979-8-3373-2096-0.ch006
10.4018/979-8-3373-2096-0.ch006
CAR-T Cell Therapy
2,025
2025-10-03
book-chapter
IGI Global Scientific Publishing
Advancements in the Diagnostics and Therapeutics for Non-Small Cell Lung Carcinoma (NSCLC)
null
null
163-196
null
9798337320960, 9798337320984
Prerna Mehta
1
G.D. Rungta College of Science and Technology, Bhilai, India
1
0
true
null
null
null
https://doi.org/10.4018/979-8-3373-2096-0.ch006
null
There is rising interest in CAR-T therapy as a potential treatment of non-small cell lung cancer (NSCLC) that comprises about 85% of all lung cancer and has a high mortality rate. This is a new technology whereby T cells are engineered to attack certain tumor-specific antigens. However, it tends to be undermined by oth...
null
ng
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.26686/wgtn.29367701
10.26686/wgtn.29367701
Honing the safety and delivery of CAR T-cell therapy
2,025
2025-06-20
dissertation
Victoria University of Wellington Library
null
null
null
null
null
null
Robert Fyfe
1
null
0
0
true
https://www.wgtn.ac.nz/library/about-us/policies-and-strategies/copyright-for-the-researcharchive
null
null
https://doi.org/10.26686/wgtn.29367701
null
<p><strong>Chimeric antigen receptor (CAR) T-cell therapy is an emerging and evolving therapy for haematological malignancies, with the potential for broader use for other malignancies and autoimmune conditions. Although this therapy is now standard of care in many countries for B-cell non-Hodgkin lymphoma,...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.31219/osf.io/ckxh5
10.31219/osf.io/ckxh5
Nonviral gene delivery vectors for transfection of the CAR gene for CAR-T cell therapy
2,021
2021-06-12
posted-content
Center for Open Science
null
null
null
null
null
null
Moataz Dowaidar
1
null
1
0
true
https://creativecommons.org/licenses/by/4.0/legalcode
null
null
https://doi.org/10.31219/osf.io/ckxh5
null
The introduction of the CAR gene via retrovirus is the most widely used and most successful technique for CAR-T cell therapy. However, the limitations and risks associated with viral gene therapy continue to motivate the development of nonviral gene delivery technologies that are potentially safer, less expensive, and ...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.20944/preprints202109.0212.v1
10.20944/preprints202109.0212.v1
An Overview of CAR T Cell Mediated B Cell Maturation Antigen Therapy
2,021
2021-09-13
posted-content
MDPI AG
null
null
null
null
null
null
Sameer Quazi
1
null
3
0
true
http://creativecommons.org/licenses/by/4.0
null
null
https://doi.org/10.20944/preprints202109.0212.v1
null
Multiple Myeloma (MM) is one of the incurable types of cancer in plasma cells. While immense progress has been made in the treatment of this malignancy, a large percentage of patients were unable to adapt to such therapy. Additionally, these therapies might be associated with significant diseases and are not always tol...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.31219/osf.io/s4bf5
10.31219/osf.io/s4bf5
The major advantages and early clinical obstacles of CAR-NK compared to CAR-T cell therapy
2,023
2023-05-24
posted-content
Center for Open Science
null
null
null
null
null
null
Chenyang Li
1
null
0
0
true
https://creativecommons.org/licenses/by/4.0/legalcode
null
null
https://doi.org/10.31219/osf.io/s4bf5
null
Chimeric Antigen Receptor T-Cells (CAR-T) are genetically engineered T cells designed to recognize and attack specific cancer cells, thereby offering a targeted approach to cancer immunotherapy. Chimeric Antigen Receptor Natural Killer (CAR-NK) cells are a novel form of such cell therapy where NK cells are genetically ...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.17504/protocols.io.rdyd27w
10.17504/protocols.io.rdyd27w
The Latest Research Progress of CAR-T Cell Therapy v1
2,018
2018-06-29
posted-content
ZappyLab, Inc.
null
null
null
null
null
null
Bella Smith
1
null
0
0
true
https://creativecommons.org/licenses/by/4.0/
null
null
https://doi.org/10.17504/protocols.io.rdyd27w
null
CAR-T (Chimeric Antigen Receptor T-Cell Immunotherapy), achimeric antigen receptor T cellimmunotherapy, has been in use for many years but has only been used in clinical practice in recent years. It has significant curative effect in the treatment of acute leukemia and non-Hodgkin'slymphoma,and is considered as one of ...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.33540/3350
10.33540/3350
Empowering CAR T Cell Therapy
2,025
2025-12-17
dissertation
Utrecht University Library
null
null
null
null
null
9789039379905, 9789039379905
Thomas Kimman
1
null
0
0
false
null
null
null
https://doi.org/10.33540/3350
null
Chimeric antigen receptors (CAR) T cell therapies have already demonstrated favourable clinical outcomes, however tumor resistance mechanisms remain a major obstacle. This thesis focuses on the primary function of CAR T cells in cancer therapy: the mechanisms by which they kill tumor cells. By gaining a fundamental und...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.70675/11e2363dzeb1fz46bcza38dz6f6c7aa5545d
10.70675/11e2363dzeb1fz46bcza38dz6f6c7aa5545d
Developing logic-gated CAR T cells for saferT-cell lymphoma therapy
2,026
2026-04-09
dissertation
Agence Bibliographique de l'Enseignement Supérieur
null
null
null
null
null
null
Estelle Bourbon
1
université Paris-Saclay
0
0
false
null
null
null
https://doi.org/10.70675/11e2363dzeb1fz46bcza38dz6f6c7aa5545d
null
CAR T cells à circuits intégrés pour améliorer leur sécurité dans le traitement des lymphomes T La thérapie par cellules T à récepteur antigénique chimérique (CAR) est apparue comme l'une des percées les plus convaincantes dans le traitement du cancer au cours de la dernière décennie. Cependant, les résultats remarquab...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.4084/mjhid.2023.066
10.4084/mjhid.2023.066
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA
2,023
2023-10-30
journal-article
Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy
Mediterranean Journal of Hematology and Infectious Diseases
15
1
e2023066
2035-3006
null
Ugo Testa, Germana Castelli, Giuseppe Leone, Elvira Pelosi, Germana Castelli, Stefan Hohaus
6
null
7
0
true
http://creativecommons.org/licenses/by-nc/4.0
null
null
https://doi.org/10.4084/mjhid.2023.066
https://www.mjhid.org/index.php/mjhid/article/download/5517/4418
Large B-cell lymphomas (LBCLs) are among the most frequent (about 30%) non-Hodgkin’s lymphoma. Despite the aggressive behavior of these lymphomas, more than 60% of patients can be cured with first-line chemoimmunotherapy using the R-CHOP regimen. Patients with refractory or relapsing disease show a poor outcome even wh...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.20944/preprints202503.1800.v1
10.20944/preprints202503.1800.v1
CAR T Cell Therapy for Rheumatoid Arthritis
2,025
2025-03-25
posted-content
MDPI AG
null
null
null
null
null
null
Michael Freeley
1
null
0
0
true
http://creativecommons.org/licenses/by/4.0
null
null
https://doi.org/10.20944/preprints202503.1800.v1
null
Chimeric Antigen Receptor (CAR) T cell therapy had revolutionised the treatment of relapsed/refractory B cell leukaemia, lymphoma and multiple myeloma. A growing body of evidence has recently demonstrated that these cell-based therapies can target autoimmune diseases including systemic lupus erythematosus, systemic scl...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.61173/b3sbkj31
10.61173/b3sbkj31
CAR-T Cell Therapy in Primary Mediastinal B-cell Lymphoma
2,025
2025-10-23
journal-article
Dean & Francis Press
MedScien
1
5
null
2960-1290
null
Fangzi Liu
1
null
0
0
true
null
null
null
https://doi.org/10.61173/b3sbkj31
https://lseee.net/index.php/ms/article/download/965/MS004792.pdf
A specific type of CAR-T cell therapy, the CAR19 therapy has demonstrated notable efficacy for relapsed or refractory (R/R) hematologic cancers, including B-cell lymphomas. After the recent reclassification of the rare subtype Primary Mediastinal B-cell Lymphoma (PMBCL) from general Diffuse Large B-cell Lymphoma (DLBCL...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1101/2020.06.20.162925
10.1101/2020.06.20.162925
Modelling CAR T-cell Therapy with Patient Preconditioning
2,020
2020-06-20
posted-content
openRxiv
null
null
null
null
null
null
Katherine Owens, Ivana Bozic
2
null
1
44
true
http://creativecommons.org/licenses/by-nc-nd/4.0/
null
null
https://doi.org/10.1101/2020.06.20.162925
null
A bstract The Federal Drug Administration (FDA) approved the first Chimeric Antigen Receptor T-cell (CAR T-cell) therapies for the treatment of several blood cancers in 2017, and efforts are underway to broaden CAR T technology to address other cancer types. Standard treatment protocols incorporate a preconditioning re...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.23880/beba-16000163
10.23880/beba-16000163
Chimeric Antigen Receptor T-Cell Therapy (Car T-Cells) in Solid Tumors, Resistance and Success
2,022
2022
journal-article
Medwin Publishers
Bioequivalence & Bioavailability International Journal
6
1
1-6
2578-4803
null
Elshimali Y
1
null
0
0
true
null
null
null
https://doi.org/10.23880/beba-16000163
https://medwinpublishers.com/BEBA/chimeric-antigen-receptor-t-cell-therapy-car-t-cells-in-solid-tumors-resistance-and-success.pdf
CARs are chimeric synthetic antigen receptors that can be introduced into an immune cell to retarget its cytotoxicity toward a specific tumor antigen. CAR T-cells immunotherapy demonstrated significant success in the management of hematologic malignancies. Nevertheless, limited studies are present regarding its efficac...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.18609/cgti.2025.013
10.18609/cgti.2025.013
Enhancing CAR-T therapy development: harnessing cell selection flexibility
2,025
2025-02-06
journal-article
BioInsights Publishing, Ltd.
Cell and Gene Therapy Insights
11
1
111–123
2059-7800
null
Tamara Laskowski, Nuala Trainor
2
Lonza, Houston, TX, USA
0
0
true
https://creativecommons.org/licenses/by-nc-nd/4.0/
null
null
https://doi.org/10.18609/cgti.2025.013
null
Clinical advancements in personalized cell therapy, particularly CAR-T cell therapy, have created a demand for innovative, closed, automated, and space-efficient manufacturing methods. Given that each therapeutic product requires a unique manufacturing process, flexibility in automation platforms is essential to accomm...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.4084/mjhid.2024.031
10.4084/mjhid.2024.031
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES
2,024
2024-02-29
journal-article
Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy
Mediterranean Journal of Hematology and Infectious Diseases
16
1
e2024031
2035-3006
null
Ugo Testa, Patrizia Chiusolo, Elvira Pelosi, Germana Castelli, Giuseppe Leone
5
null
4
0
true
http://creativecommons.org/licenses/by-nc/4.0
null
null
https://doi.org/10.4084/mjhid.2024.031
https://www.mjhid.org/mjhid/article/download/5633/4493
Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of B-cell lymphoid neoplasia and, in some instances, improved disease outcomes. Thus, six FDA-approved commercial CAR-T cell products that target antigens preferentially expressed on malignant B-cells or plasma cells have been introduced ...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.70675/580ab96fzaff1z4acfz8156z822dc6e5f3d7
10.70675/580ab96fzaff1z4acfz8156z822dc6e5f3d7
Defining the differential contributions of CD4+ and CD8+ T cells to CAR T cell therapy against B cell malignancies
2,026
2026-04-07
dissertation
Agence Bibliographique de l'Enseignement Supérieur
null
null
null
null
null
null
Morgane Boulch
1
Université Paris Cité
0
0
false
null
null
null
https://doi.org/10.70675/580ab96fzaff1z4acfz8156z822dc6e5f3d7
null
Définir les contributions différentielles des lymphocytes T CD4+ et CD8+ à la thérapie par cellules CAR T contre les cancers hématologiques Les cellules CAR T (de l'anglais Chimeric Antigen Receptor T cells) sont apparues comme étant une thérapie potentiellement curative pour le traitement de certains lymphomes et leuc...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.3324/haematol.2026.300761
10.3324/haematol.2026.300761
Unmasking the invisible: CAR T-cell therapy for intravascular large B-cell lymphoma
2,026
2026-03-12
journal-article
Ferrata Storti Foundation (Haematologica)
Haematologica
null
null
null
1592-8721, 0390-6078
null
Irit Avivi
1
null
0
0
true
http://creativecommons.org/licenses/by-nc/4.0/
null
null
https://doi.org/10.3324/haematol.2026.300761
https://haematologica.org/article/download/13395/79788
Not available.
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.61173/ccs0h933
10.61173/ccs0h933
CAR-T Cell Therapy in Acute Lymphoblastic Leukemia
2,025
2025-10-23
journal-article
Dean & Francis Press
MedScien
1
5
null
2960-1290
null
Chenyu Li
1
null
0
0
true
null
null
null
https://doi.org/10.61173/ccs0h933
https://lseee.net/index.php/ms/article/download/1040/MS005322.pdf
Acute Lymphoblastic Leukemia (ALL) is a common blood malignancy tumor that originates from the uncontrolled growth of immature lymphocytes. This process destabilizes normal hematopoiesis and gradually deteriorates the health of patients. There are some conventional treatments such as chemotherapy and hematopoietic stem...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1126/scitranslmed.abn3353
10.1126/scitranslmed.abn3353
B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function?
2,022
2022-06-22
journal-article
American Association for the Advancement of Science (AAAS)
Science Translational Medicine
14
650
null
1946-6234, 1946-6242
null
Gregory M. Chen, Jan Joseph Melenhorst, Kai Tan
3
Graduate Group in Genomics and Computational Biology, University of Pennsylvania, Philadelphia, PA, USA.
20
50
true
null
null
null
https://doi.org/10.1126/scitranslmed.abn3353
null
Chimeric antigen receptor (CAR) T cell therapies targeting CD19 and CD22 have been successful for treating B cell cancers, but CAR T cells targeting non–B cell cancers remain unsuccessful. We propose that rather than being strictly a side effect of therapy, the large number of CAR interactions with normal B cells may b...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.18609/cgti.2025.107
10.18609/cgti.2025.107
Bridging viral immunology and CAR-T therapy: leveraging natural T cell responses to enhance engineered cell therapies
2,025
2025-09-03
journal-article
BioInsights Publishing, Ltd.
Cell and Gene Therapy Insights
11
8
971–977
2059-7800
null
Catherine Bollard
1
Senior Vice President and Chief Research Officer, Children’s National Hospital, Washington, DC USA
0
0
true
https://creativecommons.org/licenses/by-nc-nd/4.0/
null
null
https://doi.org/10.18609/cgti.2025.107
null
“Success ultimately requires thoughtful clinical trial design that evaluates how...immunoengineered products...perform against exhaustion and TME suppression in comparable patient populations.” Ashling Cannon (Editor, BioInsights) speaks to Catherine Bollard (Chief Research Officer and Senior Vice President, Children’s...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1186/s13287-021-02595-0
10.1186/s13287-021-02595-0
CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
2,021
2021-10-07
journal-article
Springer Science and Business Media LLC
Stem Cell Research & Therapy
12
1
null
1757-6512
null
Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh
3
null
65
142
true
https://creativecommons.org/licenses/by/4.0
null
null
https://doi.org/10.1186/s13287-021-02595-0
https://link.springer.com/content/pdf/10.1186/s13287-021-02595-0.pdf
AbstractChimeric antigen receptor T-cell (CAR-T) therapy has been prosperous in the treatment of patients with various types of relapsed/refractory (R/R) B-cell malignancies including diffuse large B-cell lymphoma (DLBCL), B-cell acute lymphoblastic leukemia (B-ALL), follicular lymphoma (FL), mantle cell lymphoma (MCL)...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.20944/preprints202304.0482.v1
10.20944/preprints202304.0482.v1
The Black Hole: CAR T cell Therapy in AML
2,023
2023-04-18
posted-content
MDPI AG
null
null
null
null
null
null
Erden Atilla, Karim Benabdellah
2
null
11
0
true
http://creativecommons.org/licenses/by/4.0
null
null
https://doi.org/10.20944/preprints202304.0482.v1
null
Despite exhaustive studies, researchers have made little progress in the field of adoptive cellular therapies for relapsed-refractory acute myeloid leukemia (AML), unlike the notable uptake for B cell malignancies. Various single antigen targeting chimeric antigen receptor (CAR) T cell Phase I trials have been establis...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.3324/haematol.2026.301607
10.3324/haematol.2026.301607
Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma"
2,026
2026-07-23
journal-article
Ferrata Storti Foundation (Haematologica)
Haematologica
null
null
null
1592-8721, 0390-6078
null
Yushan Jin, Yuan Fang, Yao Yao
3
null
0
0
true
http://creativecommons.org/licenses/by-nc/4.0/
null
null
https://doi.org/10.3324/haematol.2026.301607
https://haematologica.org/article/download/14320/80643
Not available.
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1001/jama.2023.27885
10.1001/jama.2023.27885
T-Cell Lymphoma From CAR T-Cell Therapy—A New Safety Notice
2,024
2024-02-06
journal-article
American Medical Association (AMA)
JAMA
331
5
389
0098-7484
null
Vinay Prasad
1
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco
13
7
true
null
null
null
https://doi.org/10.1001/jama.2023.27885
https://jamanetwork.com/journals/jama/articlepdf/2814077/jama_prasad_2024_vp_230165_1706898115.66206.pdf
This Viewpoint outlines a recent safety signal identified by the FDA concerning CAR T-cell therapy for pediatric cancer, including what is known and likely implications.
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1182/blood-2023-190167
10.1182/blood-2023-190167
Exploring BiTE-Integrated CAR T-Cell Therapy to Overcome Tumor Antigen Escape and Reinforce CAR-T Therapy in Mantle Cell Lymphoma
2,023
2023-11-02
journal-article
American Society of Hematology
Blood
142
Supplement 1
6820-6820
0006-4971, 1528-0020
null
Grace Glass Crutchfield, Yang Liu, Fangfang Yan, Xiaolin Li, Heng-Huan Lee, Michael Wang, Yixin Yao
7
1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4
0
true
null
null
null
https://doi.org/10.1182/blood-2023-190167
https://ashpublications.org/blood/article-pdf/142/Supplement%201/6820/2190399/blood-3416-main.pdf
Background T cell engagers (BiTEs) are bispecific T-cell engaging antibodies that redirect T cells to target antigen-expressing tumor cells. Combining a second antigen-targeted bispecific T cell engager (BiTE) with CAR T cells or incorporating bispecific engaging antibody-secreting T cells (engager-T cells) is expected...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.18609/cgti.2025.009
10.18609/cgti.2025.009
Toward clinical-scale nonviral gene-edited CAR-NK cells for cell therapy
2,025
2025-02-13
journal-article
BioInsights Publishing, Ltd.
Cell and Gene Therapy Insights
11
1
69–84
2059-7800
null
Namritha Ravinder, Krishanu Saha
2
Director, R&D, Cell Biology, Thermo Fisher Scientific, Carlsbad, CA, USA
0
0
true
https://creativecommons.org/licenses/by-nc-nd/4.0/
null
null
https://doi.org/10.18609/cgti.2025.009
null
Improving the accessibility and effectiveness of cell therapies is essential to meet the growing demand for cancer treatments. Engineered natural killer (NK) cells represent a promising modality, offering safety, effectiveness, and the possibility of allogeneic use. This article highlights gene editing techniques such ...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1038/s41434-021-00246-w
10.1038/s41434-021-00246-w
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
2,021
2021-09
journal-article
Springer Science and Business Media LLC
Gene Therapy
28
9
513-527
0969-7128, 1476-5462
null
Nawid Albinger, Jessica Hartmann, Evelyn Ullrich
3
null
207
100
true
https://creativecommons.org/licenses/by/4.0
Deutsche Forschungsgemeinschaft
10.13039/501100001659
https://doi.org/10.1038/s41434-021-00246-w
https://www.nature.com/articles/s41434-021-00246-w.pdf
AbstractChimeric antigen receptor (CAR)-T cell therapies are on the verge of becoming powerful immunotherapeutic tools for combating hematological diseases confronted with pressing medical needs. Lately, CAR-NK cell therapies have also come into focus as novel therapeutic options to address hurdles related to CAR-T cel...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.70675/328eb98ez91a1z4d34z858bz1e70d0709083
10.70675/328eb98ez91a1z4d34z858bz1e70d0709083
Employing the tumor microenvironment to regulate CAR expression in engineered lymphocytes for safer cell therapy
2,026
2026-04-08
dissertation
Agence Bibliographique de l'Enseignement Supérieur
null
null
null
null
null
null
Enzo Manchon
1
Université Paris Cité
0
0
false
null
null
null
https://doi.org/10.70675/328eb98ez91a1z4d34z858bz1e70d0709083
null
Exploitation du microenvironnement tumoral pour réguler l'expression du CAR dans les lymphocytes génétiquement modifiés pour une thérapie cellulaire sécurisée Résumé non disponible
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1177/10430342261467645
10.1177/10430342261467645
CAR-T Cell Therapy: Manufacturing Platforms and Clinical Consequences
2,026
2026-07-10
journal-article
SAGE Publications
Human Gene Therapy
null
null
null
1043-0342, 1557-7422
null
Duc-Hiep Bach, Thanh Liem Nguyen
2
Vinmec Research Institute of Stem Cell and Gene Technology, College of Health Sciences, VinUniversity, Hanoi, Vietnam.
0
56
true
https://journals.sagepub.com/page/policies/text-and-data-mining-license
null
null
https://doi.org/10.1177/10430342261467645
https://journals.sagepub.com/doi/pdf/10.1177/10430342261467645
Chimeric antigen receptor (CAR) T-cell therapy has transformed hematological cancer care, yet variability in efficacy, durability, and safety cannot be explained solely by antigen selection or patient factors. We propose that manufacturing platforms are active biological determinants of outcome. Viral vectors, used in ...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1158/2159-8290.cd-nb2017-040
10.1158/2159-8290.cd-nb2017-040
CRISPR Meets CAR T-cell Therapy
2,017
2017-05-01
journal-article
American Association for Cancer Research (AACR)
Cancer Discovery
7
5
OF6-OF6
2159-8274, 2159-8290
null
null
0
null
1
0
true
null
null
null
https://doi.org/10.1158/2159-8290.cd-nb2017-040
https://aacrjournals.org/cancerdiscovery/article/7/5/OF6/6340/CRISPR-Meets-CAR-T-cell-TherapyCRISPR-Meets-CAR-T
Abstract Using CRISPR/Cas9 technology, researchers have devised a method to deliver a CAR gene to a specific locus, TRAC, in T cells. This targeted approach yielded therapeutic cells that were more potent even at low doses; in a mouse model of acute lymphoblastic leukemia, they outperformed CAR T cells created with a r...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.3390/v15091793
10.3390/v15091793
CAR-T Cell Therapy for HIV Cure
2,023
2023-08-23
journal-article
MDPI AG
Viruses
15
9
1793
1999-4915
null
Maria Salgado
1
AIDS Research Institute, IrsiCaixa, 08916 Barcelona, Spain
3
4
true
https://creativecommons.org/licenses/by/4.0/
null
null
https://doi.org/10.3390/v15091793
null
The HIV-1 latent reservoir is considered the major barrier to achieve the eradication, although some evidences indicate that curing HIV-1 is a feasible goal [...]
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1158/2159-8290.cd-nw2026-0078
10.1158/2159-8290.cd-nw2026-0078
First CAR T-Cell Therapy Approved for Solid Tumors
2,026
2026-07-21
journal-article
American Association for Cancer Research (AACR)
Cancer Discovery
null
null
OF1-OF1
2159-8274, 2159-8290
null
null
0
null
0
0
true
null
null
null
https://doi.org/10.1158/2159-8290.cd-nw2026-0078
https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-NW2026-0078/786956/First-CAR-T-Cell-Therapy-Approved-for-Solid
Abstract: China has approved the first CAR T-cell therapy that targets solid tumors, satricabtagene autoleucel (satri-cel), for patients with claudin 18.2–positive, HER2-negative gastric or gastro-esophageal junction cancer. The approval stems from a phase II trial that found the cells increased progression-free surviv...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.70675/2ff39929z2025z491czb6cbz30c7b9362e0f
10.70675/2ff39929z2025z491czb6cbz30c7b9362e0f
Combined nanoparticle-mediated photothermal therapy to enhance CAR-T cell immunotherapy efficacy in stiff cholangiocarcinoma
2,026
2026-04-08
dissertation
Agence Bibliographique de l'Enseignement Supérieur
null
null
null
null
null
null
Sonia Becharef
1
Université Paris Cité
0
0
false
null
null
null
https://doi.org/10.70675/2ff39929z2025z491czb6cbz30c7b9362e0f
null
Thérapie photothermique médiée par des nanoparticules pour améliorer l'efficacité de l'immunothérapie CAR-T dans le cholangiocarcinome rigide Le cholangiocarcinome (CCA) est un cancer des voies biliaires présentant une forte résistance aux traitements conventionnels. Cette résistance est principalement attribuée aux fi...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.38124/ijisrt/25jun1371
10.38124/ijisrt/25jun1371
Targeting Cancer at its Core: Cellular and Genetic Approaches Via CAR-T Cell Therapy CAR-T Cell Therapy of Cancer
2,025
2025-09-04
journal-article
International Journal of Innovative Science and Research Technology
International Journal of Innovative Science and Research Technology
null
null
3325-3337
null
null
Bandaru Aashritha, Ambati Akshara, Nandini Kongara, P. Veeresh Babu
4
null
0
43
true
null
null
null
https://doi.org/10.38124/ijisrt/25jun1371
https://www.ijisrt.com/assets/upload/files/IJISRT25JUN1371.pdf
Cancer has recently overtaken other conditions as the foremost cause of death worldwide. While numerous conventional treatment modalities and cytotoxic immunotherapies are available, the intricate nature of tumor biology— driven by a multitude of genetic and cellular factors underlying tumorigenesis and metastasis—nece...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1158/2643-3230.bcd-23-0272
10.1158/2643-3230.bcd-23-0272
The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy
2,024
2024-07-01
journal-article
American Association for Cancer Research (AACR)
Blood Cancer Discovery
5
4
249-257
2643-3230, 2643-3249
null
Mohamed Abou-el-Enein
1
Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California. 1
36
78
true
null
National Cancer Institute
10.13039/100000054
https://doi.org/10.1158/2643-3230.bcd-23-0272
https://aacrjournals.org/bloodcancerdiscov/article-pdf/doi/10.1158/2643-3230.BCD-23-0272/3451523/bcd-23-0272.pdf
Abstract The introduction of chimeric antigen receptor (CAR) T-cell therapy represents a landmark advancement in treating resistant forms of cancer such as leukemia, lymphoma, and myeloma. However, concerns about long-term safety have emerged following an FDA investigation into reports of second primary malignancies (S...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.20944/preprints202508.1325.v1
10.20944/preprints202508.1325.v1
Immune Checkpoint Inhibitors and Car-T Cell Therapy: Thrombotic and Vascular Complications
2,025
2025-08-19
posted-content
MDPI AG
null
null
null
null
null
null
Miklos Udvardy
1
null
0
0
true
http://creativecommons.org/licenses/by/4.0
null
null
https://doi.org/10.20944/preprints202508.1325.v1
null
Background: Due to the different genetic properties of malignant neoplasms and their tendency to cause the formation of blood clots, the risk of these complications is much higher than in the general population. There is even a higher risk of blood clots forming during chemotherapy or hormone therapy for cancer. Aim: T...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1182/blood-2020-140642
10.1182/blood-2020-140642
A Protease-Mediated Regulatory Chimeric Antigen Receptor (CAR): "Double Arm" CAR System Improves Tumor-Cell-Specificity of CAR-T Cell Therapy
2,020
2020-11-05
journal-article
American Society of Hematology
Blood
136
Supplement 1
41-41
0006-4971, 1528-0020
null
Satoru Aoyama, Shunichiro Yasuda, Daisuke Watanabe, Hiroki Akiyama, Yoshihiro Umezawa, Ayako Nogami, Osamu Miura, Norihiko Kawamata
8
Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
0
0
true
null
null
null
https://doi.org/10.1182/blood-2020-140642
https://ashpublications.org/blood/article/136/Supplement%201/41/471951/A-Protease-Mediated-Regulatory-Chimeric-Antigen
【 Introduction 】 CAR-T cell therapy has shown excellent therapeutic effects against some malignancies including refractory B cell lymphoma or leukemia. This adoptive T cell transfer therapy is an attractive methodology; however, there are several disadvantages to be overcome. Current CAR-T cell therapy targets single c...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.18609/cgti.2026.011
10.18609/cgti.2026.011
In vivo CAR therapy: quo vadis?
2,026
2026-02-04
journal-article
BioInsights Publishing, Ltd.
Cell and Gene Therapy Insights
12
1
87–92
2059-7800
null
Adrian Bot, Xianghong Li
2
Executive advisor, NewCo, Beverly Hills, CA, USA
0
0
true
https://creativecommons.org/licenses/by-nc-nd/4.0/
null
null
https://doi.org/10.18609/cgti.2026.011
null
In vivo CAR therapies are rapidly emerging as a strategy to address the scalability, access, and toxicity limitations associated with conventional ex vivo CAR-T cell products. This article reviews viral and LNP–RNA platform technologies, emerging clinical evidence, and key safety and regulatory considerations relative ...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1182/blood-2019-121973
10.1182/blood-2019-121973
A Novel Protease-Mediated Chimeric Antigen Receptor (CAR): "Double-Arm" CAR-T Cell System Improves Target Specificity of CAR-T Cell Therapy
2,019
2019-11-13
journal-article
American Society of Hematology
Blood
134
Supplement_1
1941-1941
0006-4971, 1528-0020
null
Satoru Aoyama, Shunichiro Yasuda, Daisuke Watanabe, Hiroki Akiyama, Yoshihiro Umezawa, Ayako Nogami, Osamu Miura, Norihiko Kawamata
8
Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
2
0
true
null
null
null
https://doi.org/10.1182/blood-2019-121973
https://ashpublications.org/blood/article/134/Supplement_1/1941/427865/A-Novel-ProteaseMediated-Chimeric-Antigen-Receptor
【 Introduction 】 CAR-T cell therapy is an attractive methodology in the field of cancer immunotherapy. Anti-CD19 CAR is used for treating refractory B cell malignancies and shows excellent therapeutic effects. However, there are several disadvantages to be overcome in this therapy. "On-target / off-tumor" effect is one...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.51731/cjht.2024.884
10.51731/cjht.2024.884
Anticytokine Therapy and Corticosteroids for Cytokine Release Syndrome and for Neurotoxicity Following T-Cell Engager or CAR T-Cell Therapy
2,024
2024-05-02
journal-article
Canadian Journal of Health Technologies, CADTH
Canadian Journal of Health Technologies
4
5
null
2563-6596
null
CADTH
1
null
2
0
true
null
null
null
https://doi.org/10.51731/cjht.2024.884
http://canjhealthtechnol.ca/index.php/cjht/article/download/RC1534/RC1534
What Is the Issue? Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are the most common toxicities secondary to T-cell engager or chimeric antigen receptor (CAR) T-cell therapy. The US FDA and Health Canada approved tocilizumab, an anti-interleukin-6 receptor antagonist...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1182/blood-2025-5484
10.1182/blood-2025-5484
Transplantation in combination with CAR T-cell therapy for refractory/relapsed aggressive B-cell lymphoma after failure of CD19 CAR-T cell therapy
2,025
2025-11-03
journal-article
American Society of Hematology
Blood
146
Supplement 1
5484-5484
0006-4971, 1528-0020
null
Fan Yang, Rui Liu, Yuelu Guo, Lixia Ma, Miaomiao Cao, Biping Deng, Haifeng Wu, Alex H. Zhang, Xiaoyan Ke, Kai Hu
10
1Department of Lymphoma and Myeloma Research Center, Beijing, China
0
0
true
null
null
null
https://doi.org/10.1182/blood-2025-5484
https://ashpublications.org/blood/article-pdf/146/Supplement%201/5484/2460962/blood-8231-main.pdf
Abstract Background: The prognosis for patients with refractory/relapsed aggressive B-cell lymphoma (R/R B-NHL) who have failed CD19 CAR-T cell therapy is exceptionally poor. Aims: This study conducted a retrospective analysis of the treatment efficacy and survival of the patients who underwent autologous transplantati...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.46765/2675-374x.2022v3n2p167
10.46765/2675-374x.2022v3n2p167
Management of Infections and Vaccination in CAR-T Cell Therapy
2,022
2022-11-23
journal-article
Journal of Bone Marrow Transplantation and Cellular Therapy
JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
3
2
167
2675-374X
null
Clarisse martins Machado
1
null
1
0
true
https://creativecommons.org/licenses/by-nc-sa/4.0
null
null
https://doi.org/10.46765/2675-374x.2022v3n2p167
https://jbmtct.sbtmo.org.br/jbmtct/article/download/167/118
Candidates for CAR-T cell therapy are at increased risk of infections due to the high degree of pre-existing immunosuppression. In addittion, the currently approved CAR-T cell therapy products have severe toxicities, including cytokine release syndrome (CRS) and immune-effector cell associated neurological syndrome (IC...
null
null
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1155/2023/8030440
10.1155/2023/8030440
Vaccine Boosting CAR-T Cell Therapy: Current and Future Strategies
2,023
2023-01-31
journal-article
Wiley
Advances in Cell and Gene Therapy
2023
null
1-9
2573-8461
null
Emmanuel Owusu Ansah, Andy Baah, Emmanuel Boateng Agyenim
3
Department of Gene Therapy, Thrivus Institute for Biomedical Science and Technology, Accra, Ghana
7
77
true
https://creativecommons.org/licenses/by/4.0/
null
null
https://doi.org/10.1155/2023/8030440
http://downloads.hindawi.com/journals/acgt/2023/8030440.pdf
Immunotherapy for cancer treatment is growing at an unprecedented rate since the inception of chimeric antigen receptor T (CAR-T) cells. However, the efficacy of CAR-T cells against solid tumors is hampered by various issues, including “on-target, off-tumor toxicities,” T cell exhaustion, and immunosuppressive tumor mi...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1158/2159-8290.cd-nd2018-008
10.1158/2159-8290.cd-nd2018-008
CAR T-cell Therapy for Solid Tumors?
2,018
2018-11-01
journal-article
American Association for Cancer Research (AACR)
Cancer Discovery
8
11
1341-1341
2159-8274, 2159-8290
null
null
0
null
9
0
true
null
null
null
https://doi.org/10.1158/2159-8290.cd-nd2018-008
https://aacrjournals.org/cancerdiscovery/article-pdf/8/11/1341/1809770/1341.pdf
Abstract Scientists have identified a wide variety of challenges preventing the development of effective CAR T-cell therapies for solid tumors, but they are investigating just as many potential solutions. Progress has been slow, but many researchers remain optimistic that successful CAR T-cell therapies, either alone o...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1097/jat.0000000000000183
10.1097/jat.0000000000000183
The Role of Physical Therapy Following CAR T-Cell Therapy: A Case Report
2,022
2022-07
journal-article
Ovid Technologies (Wolters Kluwer Health)
Journal of Acute Care Physical Therapy
13
3
152-158
2158-8686
null
Helaine Firestein
1
Helaine Firestein, PT, DPT, CLTMemorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (USA)..
2
16
true
null
null
null
https://doi.org/10.1097/jat.0000000000000183
null
Background: Diffuse large B-cell lymphoma (DLBCL) affects 7 out of 100 000 people in the United States every year. Chimeric antigen receptor (CAR) T-cell therapy is approved by the Food and Drug Administration to treat patients with relapsed/refractory DLBCL who have not responded to 2 prior lines of therapy. CAR T-cel...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1158/2159-8290.cd-nb2017-155
10.1158/2159-8290.cd-nb2017-155
FDA Approves Second CAR T-cell Therapy
2,018
2018-01-01
journal-article
American Association for Cancer Research (AACR)
Cancer Discovery
8
1
5-6
2159-8274, 2159-8290
null
null
0
null
93
0
true
null
null
null
https://doi.org/10.1158/2159-8290.cd-nb2017-155
https://aacrjournals.org/cancerdiscovery/article-pdf/8/1/5/1838844/5.pdf
Abstract The FDA approved the chimeric antigen receptor T-cell therapy axicabtagene ciloleucel, making it the second such treatment for blood cancers in the United States. The therapy is indicated for adults with certain non-Hodgkin lymphomas who have tried at least two other treatments.
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.3390/ijms21124303
10.3390/ijms21124303
CAR-T Cell Therapy
2,020
2020-06-17
journal-article
MDPI AG
International Journal of Molecular Sciences
21
12
4303
1422-0067
null
Aamir Ahmad
1
Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA
36
18
true
https://creativecommons.org/licenses/by/4.0/
null
null
https://doi.org/10.3390/ijms21124303
null
CAR-T therapy has revolutionized the treatment of select hematological malignancies, namely, acute lymphoblastic leukemia and large B-cell lymphomas [...]
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0
10.1158/2159-8290.cd-nb2017-058
10.1158/2159-8290.cd-nb2017-058
CAR T-cell Therapy: Defining Response Characteristics
2,017
2017-06-01
journal-article
American Association for Cancer Research (AACR)
Cancer Discovery
7
6
OF8-OF8
2159-8274, 2159-8290
null
null
0
null
0
0
true
null
null
null
https://doi.org/10.1158/2159-8290.cd-nb2017-058
https://aacrjournals.org/cancerdiscovery/article/7/6/OF8/6055/CAR-T-cell-Therapy-Defining-Response
Abstract Findings from a phase I study suggest that the durability of patients' response to CAR T-cell therapy, and their long-term survival, are influenced by whether they have minimal residual or morphologic disease prior to treatment. The former fared better overall, and also experienced less-severe side effects fro...
null
en
eLEugrlIHYHM872dc
kWUSK5DjJTPDAbvg0